Market Exclusivity Drives Biopharmaceutical Innovation, But Regulatory Hurdles for Biosimilars May Stifle Future Savings
Extended market exclusivity for biopharmaceuticals, as influenced by legislation like the BPCIA, appears to correlate with increased innovation in new drug development.
Academic Publication · 2018
Key Findings
- 01Legislation extending market exclusivity for biopharmaceuticals is linked to increased innovation in new biological drug development.
- 02The BPCIA introduces regulatory burdens for the development of follow-on biosimilars, potentially hindering future cost savings for patients.
Application
Design takeaway
When designing new product strategies or advocating for policy changes, consider how market exclusivity provisions influence R&D investment and the subsequent development of competing or alternative products.
How to apply
When evaluating the potential impact of new legislation or market strategies, analyze historical data to identify correlations between exclusivity periods and innovation metrics, while also assessing potential barriers to follow-on product development.
Project actions
- 01When researching a new product or technology, look for existing legislation or market conditions that might influence its development and market entry.
- 02Consider how intellectual property rights (like patents or market exclusivity) could affect both the initial innovation and the long-term availability and cost of a product.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Utilizes time-series analysis to identify trends and potential causal links.
- +Focuses on a critical and rapidly evolving industry.
Limitations
The study focuses on a specific piece of legislation and industry, so its findings might not apply to all types of innovation or all markets.
Reliability & validity
The reliability of the findings depends on the quality and completeness of the published data used for the time-series analysis. Validity is enhanced by analyzing multiple indicators of innovation and considering key legislative milestones.
Think critically
To what extent can market exclusivity be considered a purely positive driver of innovation, and what are the ethical considerations when balancing this with patient access and affordability?
Design Principles
"Incentivize novel development while facilitating accessible alternatives through thoughtful regulatory design."
Understanding the interplay between intellectual property protection and R&D investment is crucial for designing effective innovation strategies. This insight highlights how policy decisions can directly impact the pace and direction of scientific advancement in critical sectors.
What This Means for Your Design
Laws that give companies more time to be the only seller of a new medicine seem to encourage them to invent new medicines. However, these laws can also make it harder to create cheaper versions of existing medicines later on.
How to use in your project
- 1.Use this research to support arguments about how intellectual property laws can influence innovation in your design project, especially if it involves new technologies or pharmaceuticals.
Add to My Project
Quick Cite
(2018). effects of the biologics price competition and innovation act of 2009 on biopharmaceutical research and development. Academic Publication. https://doi.org/10.17760/d20284722 Retrieved from https://designdex.org/study/b8ab4a10-b0cf-4978-818f-e0cd811380d4/market-exclusivity-drives-biopharmaceutical-innovation-but-regulatory-hurdles-for-biosimilars-may-stifle-future-savings
Paragraph starter
The Biologics Price Competition and Innovation Act (BPCIA) research suggests that extended market exclusivity can stimulate innovation in biopharmaceuticals by encouraging new drug development. However, it also highlights potential drawbacks, such as regulatory hurdles for biosimilar development that may limit future cost reductions for patients. This demonstrates a complex relationship between intellectual property protection and market dynamics, where incentives for novel creation can coexist with challenges to accessibility.
Source
Academic Publication
effects of the biologics price competition and innovation act of 2009 on biopharmaceutical research and development
journal · 2018
View sourceQuestions about this research
- What does the research say about market exclusivity drives biopharmaceutical innovation, but regulatory hurdles for biosimilars may stifle future savings?
- When designing new product strategies or advocating for policy changes, consider how market exclusivity provisions influence R&D investment and the subsequent development of competing or alternative products. Evidence: Academic Publication (2018).
- Why does "Market Exclusivity Drives Biopharmaceutical Innovation, But Regulatory Hurdles for Biosimilars May Stifle Future Savings" matter for design?
- Understanding the interplay between intellectual property protection and R&D investment is crucial for designing effective innovation strategies. This insight highlights how policy decisions can directly impact the pace and direction of scientific advancement in critical sectors.
- How can designers apply this research?
- When designing new product strategies or advocating for policy changes, consider how market exclusivity provisions influence R&D investment and the subsequent development of competing or alternative products.
- What were the main findings?
- Legislation extending market exclusivity for biopharmaceuticals is linked to increased innovation in new biological drug development.. The BPCIA introduces regulatory burdens for the development of follow-on biosimilars, potentially hindering future cost savings for patients.
- What research method was used?
- Time-series analysis of published data.
- How strong is the evidence?
- Evidence strength is rated Moderate effect, based on a 2018 journal from Academic Publication.
- What should I do differently in my next project?
- When evaluating the potential impact of new legislation or market strategies, analyze historical data to identify correlations between exclusivity periods and innovation metrics, while also assessing potential barriers to follow-on product development.
- What are the limitations?
- The analysis relies on published data and may not capture all nuances of R&D investment or the full impact of regulatory burdens.
- Is there evidence that market exclusivity affects design outcomes?
- The study found that policies granting longer market exclusivity for biopharmaceuticals tend to encourage the development of new drugs, but the same legislation may create obstacles for the creation of more affordable biosimilar alternatives. Understanding the interplay between intellectual property protection and R&D Source: Academic Publication (2018).
- Where does this innovation research apply?
- Biopharmaceutical industry, regulatory policy It sits within innovation & design research on designdex.org.
Related research topics
market exclusivity design research · evidence on market exclusivity · does market exclusivity improve design outcomes · innovation studies for designers · market exclusivity and innovation findings · innovation & design research evidence